Be the first to like this
The latest Guidance from the FDA shows key takeaways for the pharma/biotech industry, i.e. brands are only responsible for the content they produce, and third party blogging will become more important in the mix. 8 case studies from large Fortune 100 companies to teensy nonprofits, and how they used social media creatively. Covers other regulated industries like financial services, vertical social networks such as Doximity, bloggers who created a market for a product from scratch, and how-tos for mining LinkedIn, Facebook, YouTube and private communities to solve challenges.